TEDDY Network as EMA stakeholder at the Second International Awareness Session for International regulators, academia and non-governamental organisations

On 8-9 March 2018, the European Medicines Agency (EMA) held “the Second International Awareness Session for international regulators, academia and non-governmental organisations”. The meeting provided the occasion to present an overall overview on how the European medicines regulatory network works as well as on the role of EMA and its interaction with scientific experts. TEDDY

April 6th, 2018|

Save the date – “EPTRI: a new European Research Infrastructure to foster the translation research in paediatrics”, April 10th, Bari (Italy)

The next meeting of the ID-EPTRI (European Paediatric Translational Research Infrastructure) project, entitled “EPTRI: una nuova Infrastruttura Europea per favorire la Ricerca Traslazionale in Pediatria” (EPTRI: a new European Research Infrastructure to foster the translation reserach in paediatrics), will be held on April 10th in Bari (Italy) at the Salone degli Affreschi of the University

April 4th, 2018|

TEDDY supports the Rare Disease Day 2018

TEDDY Network is pleased to support the Rare Disease Day 2018, that took place on February 28th, to raise awareness of rare diseases and their impact on patients' lives amongst the general public and decision-makers. The Rare Disease Day was first launched by EURORDIS and its Council of National Alliances in 2008, but soon this initiative spread all

March 1st, 2018|

EMA Videos on why EMA matters to European citizens

The European Medicines Agency (EMA) has published on EMA’s website and on the official EMA YouTube channel, three video animations to explain how it ensures that medicines are effective and safe for the benefit of patients across the European Economic Area (EEA). The first video, entitle “ Working for every patient in Europe”, explains that

February 28th, 2018|

The role of Enpr-EMA in facilitating paediatric research and in clinical trial preparedness

The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is a network of research networks, investigators and centres with recognised expertise in performing clinical studies in children. Enpr-EMA main objective is to facilitate studies in order to increase availability of medicinal products authorised for use in the paediatric population. This goal is

February 28th, 2018|

The involvement of TEDDY in the new Research Infrastructure EPTRI

        A new Paediatric Research Infrastructure (RI) is about to enter into the European scenario of the Paediatric Research. The European Paediatric Translational Research Infrastructure (EPTRI), in fact, was funded within the H2020 – INFRADEV – 01 – 2017 programme and has recently kicked-off its activities. This new RI has been designed

February 28th, 2018|

PedCrin, C4C, INCiPiT and RECLIP: the role of TEDDY in the current European scenario of the paediatric Networks

The General Assembly of TEDDY, held in Rome on 14th January 2018, has provided the occasion to meet the representatives of the current European Paediatric Networks, in which TEDDY is involved, thus giving the possibility to discuss the recent strategies of cooperation in paediatric research. The presence and the cooperation of coordinated and specialized Networks,

February 28th, 2018|

TEDDY General Assembly in Rome 2018

The General Assembly of TEDDY – European Network of Excellence for Paediatric Clinical Research took place on January 14th, 2018 in Rome (Italy). The meeting, entitled “A new phase for paediatric clinical research: a play role for TEDDY?”, provided an update on the achievements reached by the Network over the last years and represented an

February 28th, 2018|